1. Broliden, K, Tolfvenstam, T, Norbeck, O. Clinical aspects of parvovirus B19 infection. Journal of Internal Medicine 2006; 260: 285–304.
2. Tolfvenstam, T, et al. Frequency of human parvovirus B19 infection in intrauterine fetal death. Lancet 2001; 357: 1494–1497.
3. Isa, A, et al. Prolonged activation of virus-specific CD8+T cells after acute B19 infection. PLoS Medicine 2005; 2: e343.
4. Young, NS, Brown, KE. Parvovirus B19. New England Journal of Medicine 2004; 350: 586–597.
5. Zaaijer, HL, Koppelman, MH, Farrington, CP. Parvovirus B19 viraemia in Dutch blood donors. Epidemiology and Infection 2004; 132: 1161–1166.
6. Valeur-Jensen, AK, et al. Risk factors for parvovirus B19 infection in pregnancy. Journal of the American Medical Association 1999; 281: 1099–1105.
7. Ballou, WR, et al. Safety and immunogenicity of a recombinant parvovirus B19 vaccine formulated with MF59C.1. Journal of Infectious Diseases 2003; 187: 675–678.
8. Farrington, CP. Modelling forces of infection for measles, mumps and rubella. Statistics in Medicine 1990; 9: 953–967.
9. Shkedy, Z, et al. Modeling the force of infection using monotone local polynomials. Journal of the Royal Statistical Society, Series C (Applied Statistics) 2003; 52: 469–485.
10. Gay, NJ, et al. Age specific antibody prevalence to parvovirus B19: how many women are infected in pregnancy? Communicable Disease Report. CDR Review 1994; 4: R104–107.
11. van Gessel, PH, et al. Incidence of parvovirus B19 infection among an unselected population of pregnant women in the Netherlands: a prospective study. European Journal of Obstetrics, Gynecology, and Reproductive Biology 2006; 128: 46–49.
12. Ferguson, M, Heath, A. Report of a collaborative study to calibrate the Second International Standard for parvovirus B19 antibody. Biologicals 2004; 32: 207–212.
13. Kelly, HA, et al. The age-specific prevalence of human parvovirus immunity in Victoria, Australia compared with other parts of the world. Epidemiology and Infection 2000; 124: 449–457.
14. Manning, A, et al. Epidemiological profile and clinical associations of human bocavirus and other human parvoviruses. Journal of Infectious Diseases 2006; 194: 1283–1290.
15. Whitaker, HJ, Farrington, CP. Estimation of infectious disease parameters from serological survey data: the impact of regular epidemics. Statistics in Medicine 2004; 23: 2429–2443.
16. Nascimento, JP, et al. The prevalence of antibody to human parvovirus B19 in Rio de Janeiro, Brazil. Revista do Instituto de Medicina Tropical de São Paulo 1990; 32: 41–45.
17. Koch, WC, Adler, SP. Human parvovirus B19 infections in women of childbearing age and within families. Pediatric Infectious Diseases Journal 1989; 8: 83–87.
18. Alanen, A, et al. Seroprevalence, incidence of prenatal infections and reliability of maternal history of varicella zoster virus, cytomegalovirus, herpes simplex virus and parvovirus B19 infection in South-Western Finland. BJOG: An International Journal of Obstetrics and Gynaecology 2005; 112: 50–56.
19. Enders, M, Weidner, A, Enders, G. Current epidemiological aspects of human parvovirus B19 infection during pregnancy and childhood in the western part of Germany. Epidemiology and Infection 2007; 135: 563–569.
20. Edmunds, WJ, O'Callaghan, CJ, Nokes, DJ. Who mixes with whom? A method to determine the contact patterns of adults that may lead to the spread of airborne infections. Proceedings of the Royal Society of London, Series B: Biological Sciences 1997; 264: 949–957.
21. Beutels, P, et al. Social mixing patterns for transmission models of close contact infections: exploring self-evaluation and diary-based data collection through a web-based interface. Epidemiology and Infection 2006; 134: 1158–1166.
22. Ferguson, NM, et al. Strategies for mitigating an influenza pandemic. Nature 2006; 442: 448–452.
23. Wallinga, J, Teunis, P, Kretzschmar, M. Using data on social contacts to estimate age-specific transmission parameters for respiratory-spread infectious agents. American Journal of Epidemiology 2006; 164: 936–944.
24. Miller, E, et al. Immediate and long term outcome of human parvovirus B19 infection in pregnancy. British Journal of Obstetrics and Gynaecology 1998; 105: 174–178.